IDEXX LABORATORIES INC /DE AOCI Including Portion Attributable to Noncontrolling Interest, before Tax
IDEXX LABORATORIES INC /DE (IDXX) had AOCI Including Portion Attributable to Noncontrolling Interest, before Tax of $6.39 million as of 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Notes › Equity › Stockholders' Equity Note › AOCI Including Portion Attributable to Noncontrolling Interest
us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1 · last filed 2018-02-16
- 2017-12-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $6.39M.
- 2016-12-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $1.46M.
- 2016-09-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $7.99M.
- 2016-06-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $7.15M.
| Period end | AOCI Including Portion Attributable to Noncontrolling Interest, before Tax |
|---|---|
| 2017-12-31 | $6.39M 10-K · filed 2018-02-16 |
| 2016-12-31 | $1.46M 10-K · filed 2018-02-16 |
| 2016-09-30 | $7.99M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $7.15M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $5.18M 10-Q · filed 2016-04-29 |
| 2015-12-31 | -$20.21M 10-K · filed 2017-02-17 |
| 2015-09-30 | -$19.74M 10-Q · filed 2015-10-28 |
| 2015-06-30 | -$7.89M 10-Q · filed 2015-07-30 |
| 2015-03-31 | -$13.01M 10-Q · filed 2015-04-28 |
| 2014-12-31 | -$19.69M 10-K · filed 2016-02-17 |
| 2014-09-30 | -$11.53M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $1.31M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $972.00K 10-Q · filed 2014-04-25 |
| 2013-12-31 | -$442.00K 10-K · filed 2015-02-17 |
| 2013-09-30 | $1.09M 10-Q · filed 2013-10-22 |
| 2012-12-31 | $4.14M 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |